News
Press ReleaseCell and gene therapy industry continues to expand manufacturing infrastructure in the UK
Press release: GSK expands its clinical trial manufacturing capacity for cell and gene therapy at the Cell and Gene Therapy Catapult facility in StevenageRegulatory news - February 2021Press release: 2020 clinical trials database report confirms the UK as an internationally attractive clinical space for the development of cell and gene therapiesPress release: Cell and Gene Therapy Catapult appoints Dr. Ian Campbell as Innovate UK nominated non-executive DirectorPress release: Rentschler Biopharma to build new cell and gene therapy capabilities in the UKRegulatory News - January 2021CGT Catapult’s third annual clinical adoption workshop offers recommendations for advancing institutional readiness across the NHS to accelerate the routine adoption of cell and gene therapiesFebruary news: The UK's attractiveness for manufacturing ATMPsRegulatory News - December 2020Press release: Hertfordshire LEP to part-fund state-of-the-art cell and gene therapy training centre to strengthen the sector’s skills pipelineFormer CGT Catapult Chief Executive Offer awarded CBE for Services to Science and InnovationNovember/ December news: Bioprocessing of cell and gene therapies